Cognex Sees Unusually High Options Volume (NASDAQ:CGNX)

Cognex Corporation (NASDAQ:CGNX) was the recipient of some unusual options trading on Thursday. Stock investors bought 9,163 call options on the company. This is an increase of approximately 652% compared to the average daily volume of 1,218 call options.

Key Stories Impacting Cognex

Here are the key news stories impacting Cognex this week:

• Positive Sentiment: Q1 results beat expectations — Cognex reported EPS of $0.34 vs. consensus ~$0.25 and revenue of $268.4M, +24% YoY, signaling healthy demand and margin leverage. View Press Release
• Positive Sentiment: Company raised Q2 2026 guidance: EPS $0.40–$0.44 vs. street ~$0.30 and revenue guidance $280M–$300M vs. consensus ~$269M — a clear upward revision that supports near-term earnings revisions and multiple expansion. PR Newswire Release
• Positive Sentiment: Analysts and market coverage highlight the beat and momentum — coverage notes Cognex is helping drive Nasdaq tech momentum, reinforcing positive investor attention. Cognex Surge Drives Nasdaq Composite Momentum In Tech
• Positive Sentiment: Product/strategy upgrade — Cognex launched a high-performance embedded AI vision system powered by Qualcomm, which could expand addressable market in edge AI vision applications and support longer-term revenue growth. Product Launch
• Neutral Sentiment: Dividend declared — Cognex announced a quarterly dividend of $0.085/share (ex-div May 21, payable Jun 4), a modest yield (~0.5%) that signals cash return to shareholders but is small relative to growth profile.
• Neutral Sentiment: Coverage on valuation and momentum — several pieces assess valuation after the recent run-up; investors should weigh strong growth and raised guidance against a rich P/E and prior appreciation. Assessing Cognex Valuation

Cognex Price Performance

Shares of CGNX traded up $7.44 during midday trading on Thursday, reaching $69.70. The stock had a trading volume of 3,244,950 shares, compared to its average volume of 2,131,734. Cognex has a 52 week low of $28.56 and a 52 week high of $71.90. The firm’s 50 day moving average price is $52.51 and its 200-day moving average price is $45.06. The company has a market capitalization of $11.64 billion, a P/E ratio of 103.89 and a beta of 1.48.

Cognex (NASDAQ:CGNX) last released its earnings results on Wednesday, February 11th. The scientific and technical instruments company reported $0.27 EPS for the quarter, topping analysts’ consensus estimates of $0.22 by $0.05. Cognex had a net margin of 11.51% and a return on equity of 9.02%. The business had revenue of $252.34 million for the quarter, compared to the consensus estimate of $238.92 million. During the same period in the previous year, the firm earned $0.16 EPS. The business’s revenue for the quarter was up 9.9% on a year-over-year basis. On average, equities analysts forecast that Cognex will post 0.97 earnings per share for the current year.

Cognex Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Thursday, June 4th. Investors of record on Thursday, May 21st will be issued a $0.085 dividend. This represents a $0.34 dividend on an annualized basis and a dividend yield of 0.5%. The ex-dividend date is Thursday, May 21st. Cognex’s payout ratio is presently 50.75%.

Wall Street Analyst Weigh In

A number of research analysts have commented on the company. The Goldman Sachs Group increased their target price on Cognex from $50.00 to $68.00 and gave the stock a “buy” rating in a report on Tuesday, February 17th. Truist Financial reduced their target price on Cognex from $52.00 to $50.00 and set a “hold” rating on the stock in a report on Monday, April 20th. TD Cowen restated a “buy” rating on shares of Cognex in a research report on Tuesday, February 17th. Stephens raised their price target on shares of Cognex from $65.00 to $75.00 and gave the stock an “overweight” rating in a research report on Thursday. Finally, KeyCorp restated an “overweight” rating and issued a $70.00 price target (up from $50.00) on shares of Cognex in a research report on Friday, February 13th. One analyst has rated the stock with a Strong Buy rating, nine have issued a Buy rating and seven have issued a Hold rating to the stock. According to MarketBeat.com, Cognex has a consensus rating of “Moderate Buy” and a consensus price target of $60.69.

Insider Activity at Cognex

In other Cognex news, VP Laura Ann Macdonald sold 14,881 shares of the stock in a transaction on Thursday, February 12th. The shares were sold at an average price of $57.16, for a total transaction of $850,597.96. Following the transaction, the vice president directly owned 2,212 shares in the company, valued at $126,437.92. This represents a 87.06% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Robert Willett sold 177,052 shares of the business’s stock in a transaction dated Thursday, February 12th. The stock was sold at an average price of $58.39, for a total transaction of $10,338,066.28. Additional details regarding this sale are available in the official SEC disclosure. Over the last 90 days, insiders sold 196,083 shares of company stock valued at $11,419,321. Insiders own 1.70% of the company’s stock.

Institutional Investors Weigh In On Cognex

A number of institutional investors and hedge funds have recently modified their holdings of the stock. State of Michigan Retirement System raised its position in shares of Cognex by 0.5% during the first quarter. State of Michigan Retirement System now owns 39,853 shares of the scientific and technical instruments company’s stock worth $1,952,000 after purchasing an additional 200 shares during the period. Personal CFO Solutions LLC raised its position in shares of Cognex by 3.2% during the first quarter. Personal CFO Solutions LLC now owns 6,793 shares of the scientific and technical instruments company’s stock worth $333,000 after purchasing an additional 212 shares during the period. World Investment Advisors raised its position in shares of Cognex by 3.7% during the first quarter. World Investment Advisors now owns 6,073 shares of the scientific and technical instruments company’s stock worth $298,000 after purchasing an additional 214 shares during the period. Quadrant Capital Group LLC lifted its position in shares of Cognex by 1.0% in the 4th quarter. Quadrant Capital Group LLC now owns 22,907 shares of the scientific and technical instruments company’s stock valued at $824,000 after acquiring an additional 234 shares in the last quarter. Finally, Northwestern Mutual Wealth Management Co. lifted its position in shares of Cognex by 12.9% in the 2nd quarter. Northwestern Mutual Wealth Management Co. now owns 2,132 shares of the scientific and technical instruments company’s stock valued at $68,000 after acquiring an additional 243 shares in the last quarter. 88.12% of the stock is owned by institutional investors and hedge funds.

Cognex Company Profile

Cognex Corporation is a leading provider of machine vision systems, software, sensors and industrial barcode readers used to automate manufacturing, logistics and distribution processes. The company designs and develops vision-based products that help manufacturers and logistics operators inspect, identify and guide parts, assemblies and packaged goods in real time. Its solutions are applied in a broad range of industries, including automotive, electronics, semiconductor, pharmaceutical, food and beverage, and general manufacturing.

The company’s product portfolio includes stand-alone vision systems, vision sensors and deep learning-based software platforms that enable automated inspection, quality control and traceability.